These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19141695)

  • 21. Effects of a single bout of aerobic exercise on short-term low-carbohydrate/high-fat intake-induced postprandial glucose metabolism during an oral glucose tolerance test.
    Numao S; Kawano H; Endo N; Yamada Y; Konishi M; Takahashi M; Sakamoto S
    Metabolism; 2013 Oct; 62(10):1406-15. PubMed ID: 23764436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
    Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
    J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
    Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
    Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
    McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Cassader M; Durazzo M; Rizzetto M; Pagano G
    Am J Gastroenterol; 2005 Nov; 100(11):2438-46. PubMed ID: 16279898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance.
    Lin PJ; Borer KT
    PLoS One; 2016; 11(10):e0165378. PubMed ID: 27798656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.
    Bernsmeier C; Meyer-Gerspach AC; Blaser LS; Jeker L; Steinert RE; Heim MH; Beglinger C
    PLoS One; 2014; 9(1):e87488. PubMed ID: 24489924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High saturated fatty acid intake induces insulin secretion by elevating gastric inhibitory polypeptide levels in healthy individuals.
    Itoh K; Moriguchi R; Yamada Y; Fujita M; Yamato T; Oumi M; Holst JJ; Seino Y
    Nutr Res; 2014 Aug; 34(8):653-60. PubMed ID: 25172378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary 1-monoolein decreases postprandial GIP release by reducing jejunal transport of glucose and fatty acid in rodents.
    Shimotoyodome A; Osaki N; Onizawa K; Mizuno T; Suzukamo C; Okahara F; Fukuoka D; Hase T
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G298-310. PubMed ID: 22651926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia.
    Jackson KG; Zampelas A; Knapper JM; Roche HM; Gibney MJ; Kafatos A; Gould BJ; Wright JW; Williams CM
    Am J Clin Nutr; 2000 Jan; 71(1):13-20. PubMed ID: 10617941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.
    Mager DR; Mazurak V; Rodriguez-Dimitrescu C; Vine D; Jetha M; Ball G; Yap J
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):517-28. PubMed ID: 23223552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).
    Younossi ZM; Jarrar M; Nugent C; Randhawa M; Afendy M; Stepanova M; Rafiq N; Goodman Z; Chandhoke V; Baranova A
    Obes Surg; 2008 Nov; 18(11):1430-7. PubMed ID: 18500507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
    Boutari C; Stefanakis K; Simati S; Guatibonza-García V; Valenzuela-Vallejo L; Anastasiou IA; Connelly MA; Kokkinos A; Mantzoros CS
    Cardiovasc Diabetol; 2024 May; 23(1):174. PubMed ID: 38762719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.
    Musso G; Gambino R; De Michieli F; Biroli G; Premoli A; Pagano G; Bo S; Durazzo M; Cassader M
    Am J Clin Nutr; 2007 Sep; 86(3):661-71. PubMed ID: 17823431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
    Yamane S; Harada N; Inagaki N
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):20-6. PubMed ID: 27186351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.